Stay updated with breaking news from Bio pharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jennison Associates LLC trimmed its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 4.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 19,357 shares of the company’s stock after selling 944 shares during the quarter. Jennison Associates LLC’s holdings in BridgeBio Pharma were worth $781,000 at the end of […] ....
Duality Advisers LP Has $3.24 Million Stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Duality Advisers LP Buys 31,036 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
PALO ALTO, Calif., April 10, 2024 BridgeBio Pharma, Inc. , a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that on April 5, 2024, the. ....
Moody Aldrich Partners LLC decreased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 124,984 shares of the company’s stock after selling 12,528 shares during the period. Moody Aldrich Partners LLC owned about 0.07% […] ....